Immunovant, Inc. Common Stock
IMVT
IMVT: Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).
moreShow IMVT Financials
Recent trades of IMVT by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by IMVT's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on IMVT's company Twitter account
Number of mentions of IMVT in WallStreetBets Daily Discussion
Recent insights relating to IMVT
Recent picks made for IMVT stock on CNBC
ETFs with the largest estimated holdings in IMVT
Flights by private jets registered to IMVT